InVitae (NVTA) Shares Up 6.4%
InVitae Corp (NYSE:NVTA) shares shot up 6.4% on Tuesday . The stock traded as high as $9.24 and last traded at $9.18. 692,147 shares changed hands during trading, a decline of 15% from the average session volume of 809,958 shares. The stock had previously closed at $8.63.
Several brokerages recently weighed in on NVTA. BidaskClub cut InVitae from a “buy” rating to a “hold” rating in a research report on Thursday, October 26th. Zacks Investment Research cut InVitae from a “hold” rating to a “sell” rating in a research report on Thursday, January 4th. Leerink Swann cut their price objective on InVitae from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Tuesday, November 7th. Finally, Ladenburg Thalmann Financial Services started coverage on InVitae in a research report on Friday, January 5th. They issued a “buy” rating and a $15.00 price objective for the company. Three research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. InVitae presently has an average rating of “Hold” and an average target price of $13.80.
The firm has a market capitalization of $492.39 and a PE ratio of -3.65. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.61 and a current ratio of 2.61.
Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.
Receive News & Ratings for InVitae Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InVitae and related companies with MarketBeat.com's FREE daily email newsletter.